Thread

1. modeless · 1790190319 · focus · HN ↗

   It's clear Dario believes that the solution to AI's PR problem is to cure cancer. Or invent other revolutionary medical treatments. They're going to heavily promote every step along the way no matter how small or far away from commercialization they are, like this one.

   No doubt that curing cancer would help, but I think the timeline might be a little too long. Even RSI AGI will not be able to get new medical treatments to market instantly. Real world testing takes a long time and is an unavoidable part of the process.

   1. JoeOfTexas · 1790190568 · focus · HN ↗

      Cancer can be cured in a lot of cases, its just so damn expensive and the treatment is beyond torturous that some patients cannot handle it. Stem cells are amazing. But we need cheaper technology to replicate them into the cancer destroyers they need to be, as well as find ways to ease the pain of that internal battle.

      1. Aboutplants · 1790190673 · focus · HN ↗

         Please tell me more about these “cures” you speak of. Because to my knowledge, yes we are good at getting patients into remission, we do not have “cures” Coupled with the fact that treatment is often life altering in and of itself

         1. sourcinnamon · 1790191167 · focus · HN ↗

            In addition to the other comment mentioning CAR-T therapies, we also have therapies based on tumor-infiltrating lymphocytes (TILs)

            <a href="https:&#x2F;&#x2F;www.cancer.gov&#x2F;news-events&#x2F;cancer-currents-blog&#x2F;2024&#x2F;fda-amtagvi-til-therapy-melanoma" rel="nofollow">https:&#x2F;&#x2F;www.cancer.gov&#x2F;news-events&#x2F;cancer-currents-blog&#x2F;2024...

            <a href="https:&#x2F;&#x2F;jitc.bmj.com&#x2F;content&#x2F;8&#x2F;2&#x2F;e000848" rel="nofollow">https:&#x2F;&#x2F;jitc.bmj.com&#x2F;content&#x2F;8&#x2F;2&#x2F;e000848 (careful: Figure 1 can be very graphical, but it shows the huge positive impact of this therapy)

            We also have therapies based on monoclonal recombinant antibodies conjugated with chemotherapeutics. Simply put, we can produce antibodies that are specific for markers present in the surface of cancer cells, and we can attach drugs that can kill those cells. The antibody part is what makes this type of therapy very effective (you target only cancer cells, and not healthy cells) and also very expensive.

            1. D-Machine · 1790237028 · focus · HN ↗

               There is no world in which CAR-T is a &quot;cure&quot;, especially since this isn&#x27;t even a scientific term in oncology. We generally say if there is no relapse after 5 years post-treatment, then any cancer is a &quot;new&quot; cancer, so 5 years of remission is the closest thing to a &quot;cure&quot;, but this isn&#x27;t a scientific term.

               Also, we barely have more than 3 years data for CAR-T for most cancers. And even still, the survival rates aren&#x27;t great, in many cases 50% compared to e.g. &lt;20% for previous chemo-immunotherapies plus marrow transplants. And this ignores how massively immunocompromised CAR-T leaves you (for at least a year in close to half of cases, but maybe even permanently, in perhaps as high as 10% of cases, at least for some lymphomas).

               I say this as a person that is only alive because of CAR-T treatment 1.5 years ago.

Unofficial Hacker News client; not affiliated with Y Combinator.